SCHEMBL6311463

SCHEMBL6311463

O=C(O)c1ccc2c(c1)nc1ccccn12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.55
ALDH1A1 P00352 5/20 0.55
GAA P10253 5/20 0.55
GLA P06280 5/20 0.55
HPGD P15428 4/20 0.53
POLB P06746 3/20 0.53
KMT2A Q03164 3/20 0.53
MEN1 O00255 2/20 0.53
NPC1 O15118 2/20 0.53
RAB9A P51151 2/20 0.53
MAPT P10636 2/20 0.53
HSD17B10 Q99714 2/20 0.52
HSP90AA1 P07900 1/20 0.52
HSP90AB1 P08238 1/20 0.52
THRB P10828 1/20 0.52
RECQL P46063 1/20 0.52
YWHAG P61981 1/20 0.52
CSNK2A2 P19784 2/20 0.49
CSNK2B P67870 2/20 0.49
CSNK2A1 P68400 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6313080 0.88 KDM4E (0.59) KDM4EALDH1A1GAAGLAHPGD
Doqualast SCHEMBL124450 0.79 KDM4E (0.63) KDM4EALDH1A1GAAGLAHPGD
SCHEMBL19735198 0.74 KDM4E (0.60) KDM4EALDH1A1GAAGLAHPGD
SCHEMBL832842 0.74 KDM4E (0.63) KDM4EALDH1A1GAAGLAHPGD
SCHEMBL24553486 0.74 ALDH1A1 (0.60) KDM4EALDH1A1GAAGLAHPGD
SCHEMBL13056888 0.74 CSNK2A1 (0.79) CSNK2A2CSNK2BCSNK2A1
SCHEMBL839837 0.73 ALDH1A1 (0.62) KDM4EALDH1A1GAAGLAHPGD
SCHEMBL13411342 0.72 KDM4E (0.69) KDM4EALDH1A1GAAGLAHPGD
SCHEMBL29892844 0.72 HSD17B10 (0.55) KDM4EALDH1A1GAAGLAHPGD
SCHEMBL29892764 0.72 HPGD (0.47) KDM4EALDH1A1GAAHPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2005-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative MANBA, MAN2B1, ERG28 KDM4E 3360/4885ALDH1A1 2550/4885GAA 58/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.